The dates and venue for the upcoming Hematology event will be announced shortly.
For further details, Please contact us at secretary@magnusmeetings.com or call + 1 (702) 988 2320.
Epidemiology is the study and analysis of health and disease situations in specified populations, including their distribution (who, when, and where), patterns, and factors. It is a cornerstone of public health, influencing policy and evidence-based practise by identifying disease risk factors and preventative healthcare priorities. Epidemiologists assist in study design, data collection, statistical analysis, interpretation, and dissemination (including peer review and ccasional systematic review). Epidemiology has aided in the development of techniques for clinical research, public health investigations, and, to a lesser extent, basic biological science research. The measurement of disease outcomes in relation to a population at risk is a key component of epidemiology. The population at risk is a group of people, healthy or sick, who would be considered cases if they had the disease under investigation.
Epigenetics is the study of how your behaviour and environment can influence how your genes function. Epigenetic alterations, unlike genetic changes, are reversible and do not alter your DNA sequence; nevertheless, they can alter how your body interprets a DNA sequence. The study of how cells influence gene activity without modifying the DNA sequence is known as epigenetics. In Greek, "epi-" means "on or above," thus "epigenetic" refers to influences other than the genetic code. Modifications to DNA that control whether genes are turned on or off are known as epigenetic changes. These changes are made to DNA and do not alter the sequence of the DNA building units.
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan Lluis Vives Corrons, Institute for Leukaemia Research Josep Carreras, Spain
Title : Histologic transformation of mantle zone lymphoma to diffuse large B-Cell lymphoma: A case report of disease relapse after Covid-19 infection
Lilija Bancevica, Riga Stradins University, Latvia
Title : Improving outcomes of curable lymphoma in resource constrained regions
Reena Nair, TATA Medical Centre, India
Title : Covid-19 and erythrocyte groups
Marina Nagervadze, Batumi Shota Rustaveli State University, Georgia
Title : Achieving 100% blood traceability compliance: A United Kingdom district hospital experience
Francis Ajeneye, Princess Alexandra Hospital NHS Trust, United Kingdom
Title : Role of erythrocytapheresis in sickle cell anemia crisis management: A tertiary care centre experience from Chhattisgarh state of central India
Neelesh Jain, Transfusion Medicine at Balco Medical Centre, India